Trial site
Wake Forest Baptist Health
- 22running trials
- 30closed trials
The trials here
What the 52 trials at this site are about, from their registry records.
- Conditions
- Lung cancer5 trials
- Stroke5 trials
- Diffuse large B-cell lymphoma4 trials
- Epilepsy4 trials
- Osteoarthritis4 trials
- Acute myeloid leukaemia3 trials
- Alzheimer disease3 trials
- Chronic lymphocytic leukaemia3 trials
- Cystic fibrosis3 trials
- Acute lymphoblastic leukaemia2 trials
- Atrial fibrillation2 trials
- Brain aneurysm2 trials
- and 32 more
- Phase
- Phase 321 trials
- Phase 29 trials
- Phase 1/24 trials
- Phase 13 trials
- Status
- Completed22 trials
- Active, not recruiting13 trials
- Recruiting7 trials
- Terminated4 trials
- Withdrawn4 trials
- Not yet recruiting2 trials
- Lead sponsor
- Wake Forest University Health Sciences6 trials
- Vertex Pharmaceuticals Incorporated4 trials
- Bayer3 trials
- BioAtla, Inc.2 trials
- Calibr, a division of Scripps Research2 trials
- and 34 more
Running trials
Recruiting
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Phase 1/2 Study of VX-670 in Adult Participants With Myotonic Dystrophy 1 (DM1)
Recruiting
Active, not recruiting
Recruiting
The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation
Recruiting
A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures
Active, not recruiting
A Study Evaluating the Long-term Safety and Efficacy of VX-121 Combination Therapy
Active, not recruiting
Active, not recruiting
Active, not recruiting
Regulating Blood Pressure During Recovery From Intracerebral Hemorrhage and Ischemic Stroke
Recruiting
Determinants of Incident Stroke Cognitive Outcomes and Vascular Effects on RecoverY
Active, not recruiting
A Study of Etavopivat in Adults and Adolescents With Sickle Cell Disease (HIBISCUS)
Active, not recruiting
Recruiting
Active, not recruiting
Recruiting
Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia
Active, not recruiting
Phase 1-2 Study of ASTX660 in Subjects With Advanced Solid Tumors and Lymphomas
Recruiting
Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
Recruiting
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Idiopathic pulmonary fibrosis2 recruiting
- Stroke2 recruiting
- Acute lymphoblastic leukaemia1 recruiting
- Acute myeloid leukaemia1 recruiting
- Alzheimer disease1 recruiting
- Atrial fibrillation1 recruiting
- Bladder cancer1 recruiting
- Brain aneurysm1 recruiting
- Chronic lymphocytic leukaemia1 recruiting
- Chronic myeloid leukaemia1 recruiting
- Epilepsy1 recruiting
- Hodgkin lymphoma1 recruiting
- Mild cognitive impairment1 recruiting
- Multiple myeloma1 recruiting
- Myelodysplastic syndromes1 recruiting
Closed trials
Withdrawn
Validate a Pharmacodynamic Model of Oxytocin for Peripheral Analgesic Effects
Completed
Assessing Comorbidities in Epilepsy Using Eye Movement Recordings
Withdrawn
Withdrawn
Completed
A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures
Completed
Terminated
Withdrawn
Terminated
Completed
Completed
Completed
Completed
Completed
Long-term Follow-up Study for Patients Treated With CLBR001 CAR-T
Terminated
Completed
Completed
CLBR001 and SWI019 in Patients With Relapsed / Refractory B-cell Malignancies
Completed
Completed
Completed
Terminated
Completed
ADvance II Study: DBS-f in Patients With Mild Alzheimer's Disease
Completed
Completed
Completed
CAB-AXL-ADC Safety and Efficacy Study in Adult and Adolescent Patients With Sarcoma
Completed
Stereotactic Laser Ablation for Temporal Lobe Epilepsy (Slate)
Completed
Recruiting
JoLT-Ca Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) for Lung Cancer
Completed
Treatment in Preventing Anal Cancer in Patients With HIV and Anal High-Grade Lesions
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026